Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Lung Cancer Treatments and Mutations, Cancer, Hypoxia, and Metabolism, Peroxisome Proliferator-Activated Receptors, and Lung Cancer Diagnosis and Treatment.
Disruption of the Clock Component Bmal1 in Mice Promotes Cancer Metastasis through the PAI‐1‐TGF‐<i>β</i>‐myoCAF‐Dependent Mechanism
Mirabegron displays anticancer effects by globally browning adipose tissues
KRAS mutation-driven angiopoietin 2 bestows anti-VEGF resistance in epithelial carcinomas
FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis
Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel–Lindau syndrome
COVID-19 instigates adipose browning and atrophy through VEGF in small mammals
Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism
Eradication of tumor growth by delivering novel photothermal selenium-coated tellurium nanoheterojunctions
Therapeutic paradigm of dual targeting VEGF and PDGF for effectively treating FGF-2 off-target tumors
Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance